Rahul Kota | Cancer Genetics | Young Scientist Award

Young Scientist Award

Rahul Kota
QIS College of Pharmacy, India

Rahul Kota
Affiliation QIS College of Pharmacy
Country India
Subject Area Cancer Genetics
Event International Research Awards on Oncology and Cancer Research
ORCID 0009-0007-0528-4865

Rahul Kota is affiliated with QIS College of Pharmacy in India and is identified with the subject area of cancer genetics. Cancer genetics examines the relationship between genetic variation, genomic alterations, inherited susceptibility, and the development or progression of cancer. The field contributes to understanding molecular mechanisms of disease and can support the development of improved approaches to cancer risk assessment, diagnosis, classification, and treatment. [1]

Abstract

This academic recognition profile concerns Rahul Kota of QIS College of Pharmacy, India, whose stated subject area is Cancer Genetics. Cancer genetics is an interdisciplinary area within biomedical and oncology research that investigates genetic and genomic factors associated with cancer initiation, susceptibility, progression, and therapeutic response. Modern cancer research increasingly integrates molecular genetics with genomic technologies to characterize tumor biology and identify clinically relevant alterations. [1]

Keywords

Cancer Genetics; cancer genomics; oncology research; genetic variation; tumor genetics; molecular oncology; genomic medicine; cancer susceptibility; precision oncology; biomedical research; young scientist; cancer research.

Introduction

Cancer is fundamentally a disease involving alterations to cellular genetic and regulatory processes. Genetic changes may arise through inherited variation or accumulate during an individual’s lifetime, with combinations of genomic alterations influencing tumor development and biological behavior. Large-scale genomic studies have demonstrated substantial molecular diversity among cancers, supporting the classification of tumors according to their underlying molecular characteristics. [2]

Research Profile

Rahul Kota is associated with QIS College of Pharmacy and has been identified for this profile under the research area of Cancer Genetics. The supplied researcher identifier is ORCID 0009-0007-0528-4865, providing a persistent digital identifier that can be used to distinguish a researcher from other individuals with similar names.

Research Contributions

Within cancer genetics, research contributions may encompass investigation of inherited and acquired genetic alterations, molecular mechanisms of tumor development, genetic determinants of cancer susceptibility, genomic characterization of tumors, and the interpretation of molecular information for oncology applications. Cancer-associated genetic alterations can affect pathways involved in cell proliferation, DNA repair, apoptosis, and other processes relevant to malignant transformation. [3]

Publications

No verified publication list was supplied for this profile. Consequently, individual publications, journal articles, citation counts, and DOI records are not attributed to Rahul Kota in order to avoid conflating publications by researchers with similar names.For a formal academic evaluation, publications should be verified through authoritative scholarly records and matched using persistent identifiers, institutional affiliation, subject area, authorship information, and DOI metadata where available.

Research Impact

Cancer genetics has substantial relevance to contemporary oncology because genomic information can improve understanding of disease heterogeneity and provide a foundation for molecularly informed clinical research. The identification and interpretation of cancer-associated alterations have become important components of translational oncology and precision-medicine research. [2] [3]

Award Suitability

The Young Scientist Award is presented here within the context of the International Research Awards on Oncology and Cancer Research. Rahul Kota’s supplied affiliation with QIS College of Pharmacy and stated specialization in Cancer Genetics establish a subject-area connection with oncology and cancer research.Based solely on the supplied information, the profile demonstrates thematic alignment with the award’s oncology research scope. A complete award assessment would additionally require verification of eligibility criteria, research outputs, publication record, originality of contributions, and other evaluation requirements established by the award program.

Conclusion

Rahul Kota, affiliated with QIS College of Pharmacy in India, is profiled within the field of Cancer Genetics for consideration under the Young Scientist Award associated with the International Research Awards on Oncology and Cancer Research. The available information supports a clear subject-area relationship with oncology research. Further assessment of scholarly achievement should be based on verified publication, citation, authorship, and research-impact evidence.

References

1. Hanahan, D. (2022). Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12(1), 31–46.
        https://doi.org/10.1158/2159-8290.CD-21-1059

2. The Cancer Genome Atlas Research Network. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics, 45, 1113–  1120.                         https://doi.org/10.1038/ng.2764

3. National Cancer Institute. (n.d.). Precision Medicine in Cancer. National Institutes of Health.
         https://www.cancer.gov/research/infrastructure/precision-medicine

4. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., Jr., & Kinzler, K. W. (2013). Cancer Genome Landscapes. Science, 339(6127),          1546–1558.
         https://doi.org/10.1126/science.1235122

5. ORCID. (n.d.). ORCID: Connecting Research and Researchers.
          https://orcid.org/

LEANDRO RESENDE | Oncology and precision medicine | Innovative Research Award

Innovative Research Award

LEANDRO RESENDE
Rede Dor

LEANDRO RESENDE
Affiliation Rede Dor
Country Brazil
Scopus ID 57188977624
Documents 5
Citations 35
h-index 3
Subject Area Oncology and precision medicine
Event International Research Awards on Oncology and Cancer Research
Scopus Author Profile

LEANDRO RESENDE is a researcher affiliated with Rede Dor in Brazil whose documented scholarly profile is associated with oncology and precision medicine.The Innovative Research Award profile presents this research activity within the broader context of contemporary cancer science, where molecular characterization, individualized treatment strategies, biomarkers, and evidence-based clinical decision-making increasingly intersect. Precision oncology seeks to connect biological information with clinically meaningful therapeutic choices. [1]

Abstract

The Innovative Research Award profile recognizes the research record of LEANDRO RESENDE, affiliated with Rede Dor, Brazil, in the field of oncology and precision medicine. The documented Scopus profile reports five scholarly documents, 35 citations, and an h-index of 3. [1] These indicators provide a bibliometric snapshot of published research and citation activity.Within modern oncology, precision medicine emphasizes the integration of molecular, clinical, and pathological information to support more individualized approaches to cancer investigation and treatment.

Keywords

  • Innovative Research Award
  • Oncology
  • Precision Medicine
  • Cancer Research
  • Biomedical Research
  • Research Impact

Introduction

Cancer research increasingly depends on interdisciplinary approaches that connect molecular biology, clinical medicine, pathology, genomics, and computational analysis. Precision medicine has developed as an important framework for identifying biological differences between tumors and using those differences to inform research and therapeutic strategies. [3]Against this background, researchers working across oncology contribute to a continually expanding evidence base.

Research Profile

LEANDRO RESENDE is affiliated with Rede Dor in Brazil and is represented in Scopus under Author ID 57188977624. The supplied profile records five documents, 35 citations, and an h-index of 3. [1] The stated subject area is oncology and precision medicine, placing the research profile within a clinically and scientifically significant field.

Research Contributions

Contemporary cancer frameworks emphasize multiple interacting characteristics of malignant disease, including genomic instability, cellular signaling, immune interactions, and the tumor microenvironment. [3]The documented bibliometric record offers measurable evidence of scholarly dissemination, while the specific scientific significance of individual publications should be evaluated through their methods, findings, citations, and subsequent use by other researchers.

Publications

The supplied Scopus record identifies five documents associated with the researcher. [1] Because complete publication titles, journal information, publication years, and DOI identifiers were not supplied with the profile data, this article does not assign specific publication details that cannot be independently established from the provided record.

Research Impact

The reported total of 35 citations indicates that the indexed documents have been cited within the scholarly literature. The h-index of 3 further describes a citation distribution in which at least three documents have each received at least three citations, subject to the indexing and counting methodology used by the database. [1]Citation metrics are useful descriptive measures but do not independently determine scientific quality or societal impact.

Award Suitability

The supplied research profile is aligned thematically with an award focused on oncology and cancer research because the stated subject area is oncology and precision medicine. The documented publication and citation record provides an objective basis for describing established scholarly activity. [1]Final award assessment should be based on the organizer’s published eligibility criteria, submitted evidence, peer or committee evaluation, and the originality and significance of the candidate’s research.

Conclusion

LEANDRO RESENDE’s supplied academic profile documents research activity associated with Rede Dor, Brazil, and the fields of oncology and precision medicine. The Scopus record reports five documents, 35 citations, and an h-index of 3, providing a concise bibliometric description of the researcher’s indexed scholarly output. [1]The Innovative Research Award profile places these activities within the wider development of precision oncology and evidence-based cancer research.

References

  1. Elsevier. (n.d.). Scopus author details: LEANDRO RESENDE, Author ID 57188977624. Scopus.
    https://www.scopus.com/pages/authors/57188977624
  2. National Cancer Institute. (n.d.). Precision Medicine in Cancer Treatment. National Cancer Institute.
    https://www.cancer.gov/about-cancer/treatment/types/precision-medicine
  3. Hanahan, D. (2022). Hallmarks of Cancer: New Dimensions. Cell, 185(1), 31–41. DOI: 10.1016/j.cell.2021.12.029.
    https://doi.org/10.1016/j.cell.2021.12.029
  4. Ashley, E. A. (2016). Towards precision medicine. Nature Reviews Genetics, 17, 507–522. DOI: 10.1038/nrg.2016.86.
    https://doi.org/10.1038/nrg.2016.86
  5. International Research Awards on Oncology and Cancer Research. (n.d.). Official Award Website.
    https://oncology.pencis.com/